AngioDynamics, Inc. (ANGO) vs Helus Pharma Inc. (HELP)
A side-by-side comparison of AngioDynamics, Inc. and Helus Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANGO
AngioDynamics, Inc.
$15.01HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
HELP
Helus Pharma Inc.
$10.62HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — ANGO vs HELP
growth of $100 · dividends reinvested · last 1yANGO +19.8% (+19.8%/yr)HELP +93.2% (+93.2%/yr)HELP compounded faster over this window
ANGO HELP
ANGO vs HELP: by the numbers
- •HELP is the larger company ($659M vs $620M market cap).
- •HELP is profitable (329.09% net margin) while ANGO runs a net loss (-11.48%).
Metrics side by side
Valuation
| Metric | ANGO | HELP |
|---|---|---|
| P/S ratio | 1.94 | N/A |
| P/B ratio | 3.63 | 2.72 |
| FCF yield | 0.08% | N/A |
Profitability
| Metric | ANGO | HELP |
|---|---|---|
| Gross margin | 54.62% | 100.27% |
| Operating margin | -12.47% | 317.06% |
| Net margin | -11.48% | 329.09% |
| ROE | -21.51% | -75.79% |
| ROIC | -20.75% | -73.27% |
Growth (annualized)
| Metric | ANGO | HELP |
|---|---|---|
| Revenue CAGR (5Y) | 1.93% | N/A |
| FCF CAGR (5Y) | -51.49% | N/A |
| Total return CAGR (5Y) | -10.80% | N/A |
Frequently asked
- Is ANGO or HELP more profitable?
- HELP runs the higher net margin — ANGO at -11.48% versus HELP at 329.09%.
Go deeper
Dig into the metrics
AngioDynamics ROEHelus Pharma ROEAngioDynamics operating marginHelus Pharma operating marginAngioDynamics revenue growthHelus Pharma revenue growthAngioDynamics free cash flowHelus Pharma free cash flow
AngioDynamics & Helus Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.